Galapagos NV
GLPG
#5080
Rank
$1.86 B
Marketcap
$27.73
Share price
0.00%
Change (1 day)
-2.87%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of March 2026 : $7.44 Million USD

According to Galapagos NV's latest financial reports the company's total debt is $7.44 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2026)

Total debt by year

Year Total debt Change
2024-12-31$12.19 M14.99%
2023-12-31$10.6 M-54.85%
2022-12-31$23.49 M-22.77%
2021-12-31$30.41 M-15.99%
2020-12-31$36.2 M27.32%
2019-12-31$28.43 M
2018-12-31N/A-100%
2017-12-31$0.01 M-83.7%
2016-12-31$0.06 M-47.3%
2015-12-31$0.12 M-38.09%
2014-12-31$0.2 M-62.58%
2013-12-31$0.54 M1.31%
2012-12-31$0.53 M-52.91%
2011-12-31$1.13 M-31.3%
2010-12-31$1.65 M-22.11%
2009-12-31$2.12 M-9.8%
2008-12-31$2.35 M-63.04%
2007-12-31$6.37 M-37.77%
2006-12-31$10.24 M8.59%
2005-12-31$9.43 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
$54.98 B 738,178.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$34.04 B 457,029.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$72.85 B 978,122.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$23.17 B 311,026.48%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$49.11 B 659,365.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$33.91 B 455,297.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$25.23 B 338,734.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
$68.29 M 816.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$16.90 B 226,900.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel